scholarly article | Q13442814 |
P50 | author | Susanne Feil | Q30380372 |
Sebastian Vogel | Q52654318 | ||
Johannes Rheinlaender | Q52654330 | ||
Tilman E. Schäffer | Q57026808 | ||
Julia-Stefanie Frick | Q73638718 | ||
Simon C Watkins | Q87981821 | ||
Michael T Lotze | Q89121415 | ||
Meinrad Gawaz | Q89518767 | ||
Oliver Borst | Q117266809 | ||
P2093 | author name string | Patrick J Pagano | |
Patrick Münzer | |||
Grant C Bullock | |||
Robert Feil | |||
Erwin Bohn | |||
Timothy R Billiar | |||
Brian S Zuckerbraun | |||
Qiwei Chen | |||
Jason L Sperry | |||
Matthew D Neal | |||
Patricia Loughran | |||
Gabor Csanyi | |||
Britta Walker | |||
Justin Markel | |||
Morgan E Jessup | |||
Rebecca Bodenstein | |||
P2860 | cites work | Extracellular DNA traps promote thrombosis. | Q24613579 |
Platelets in tissue repair: control of apoptosis and interactions with regenerative cells | Q26862152 | ||
Emerging roles for platelets as immune and inflammatory cells | Q27016553 | ||
Damage-associated molecular pattern-activated neutrophil extracellular trap exacerbates sterile inflammatory liver injury | Q27334890 | ||
Release of chromatin protein HMGB1 by necrotic cells triggers inflammation | Q28131815 | ||
HMG-1 as a late mediator of endotoxin lethality in mice | Q28139166 | ||
Platelets, inflammation and tissue regeneration | Q28235158 | ||
High mobility group box 1 protein interacts with multiple Toll-like receptors | Q28280114 | ||
Extracellular cyclophilin A activates platelets via EMMPRIN (CD147) and PI3K/Akt signaling, which promotes platelet adhesion and thrombus formation in vitro and in vivo. | Q30316872 | ||
Highly specific, membrane-permeant peptide blockers of cGMP-dependent protein kinase Ialpha inhibit NO-induced cerebral dilation | Q31836174 | ||
Reduced microvascular thrombosis and improved outcome in acute murine stroke by inhibiting GP IIb/IIIa receptor-mediated platelet aggregation | Q32000831 | ||
Platelet Toll-like receptor expression modulates lipopolysaccharide-induced thrombocytopenia and tumor necrosis factor-alpha production in vivo | Q33368585 | ||
Lipopolysaccharide stimulates platelet secretion and potentiates platelet aggregation via TLR4/MyD88 and the cGMP-dependent protein kinase pathway | Q33384817 | ||
Activated platelets interfere with recruitment of mesenchymal stem cells to apoptotic cardiac cells via high mobility group box 1/Toll-like receptor 4-mediated down-regulation of hepatocyte growth factor receptor MET | Q33676193 | ||
The vasodilator-stimulated phosphoprotein (VASP) is involved in cGMP- and cAMP-mediated inhibition of agonist-induced platelet aggregation, but is dispensable for smooth muscle function. | Q33890246 | ||
Prehospital use of nonsteroidal anti-inflammatory drugs (NSAIDs) is associated with a reduced incidence of trauma-induced coagulopathy | Q33896084 | ||
Platelet-derived Toll-like receptor 4 (Tlr-4) is sufficient to promote microvascular thrombosis in endotoxemia. | Q34387761 | ||
Systemic inflammation and liver injury following hemorrhagic shock and peripheral tissue trauma involve functional TLR9 signaling on bone marrow-derived cells and parenchymal cells. | Q34400381 | ||
Disseminated intravascular coagulation in trauma patients | Q34461301 | ||
Platelets release mitochondria serving as substrate for bactericidal group IIA-secreted phospholipase A2 to promote inflammation | Q34660102 | ||
Toll-like receptor 4 regulates platelet function and contributes to coagulation abnormality and organ injury in hemorrhagic shock and resuscitation | Q34734986 | ||
DNA attenuates enterocyte Toll-like receptor 4-mediated intestinal mucosal injury after remote trauma | Q34979970 | ||
Platelets in atherothrombosis | Q34986345 | ||
Cytosolic HMGB1 controls the cellular autophagy/apoptosis checkpoint during inflammation. | Q35183879 | ||
Biphasic roles for soluble guanylyl cyclase (sGC) in platelet activation | Q35266258 | ||
Cyclic GMP-dependent protein kinases and the cardiovascular system: insights from genetically modified mice. | Q35582722 | ||
Differential dynamics of platelet contact and spreading | Q35743292 | ||
HMGB1 is a therapeutic target for sterile inflammation and infection | Q35953553 | ||
Necrotic cell-derived high mobility group box 1 attracts antigen-presenting cells but inhibits hepatocyte growth factor-mediated tropism of mesenchymal stem cells for apoptotic cell death. | Q36067773 | ||
Platelets induce neutrophil extracellular traps in transfusion-related acute lung injury | Q36068299 | ||
Platelets in inflammation and atherogenesis. | Q36328825 | ||
The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion | Q36403403 | ||
Circulating histones are mediators of trauma-associated lung injury. | Q36605094 | ||
Endothelial TLR4 activation impairs intestinal microcirculatory perfusion in necrotizing enterocolitis via eNOS-NO-nitrite signaling | Q36915561 | ||
Conditional ablation of HMGB1 in mice reveals its protective function against endotoxemia and bacterial infection | Q37409524 | ||
Intracellular Hmgb1 inhibits inflammatory nucleosome release and limits acute pancreatitis in mice | Q37662678 | ||
Arterial thrombosis--insidious, unpredictable and deadly | Q37953778 | ||
HMGB1 and leukocyte migration during trauma and sterile inflammation | Q38064648 | ||
Role of multiligand/RAGE axis in platelet activation. | Q38167989 | ||
Pseudofracture: an acute peripheral tissue trauma model | Q38353270 | ||
Hepatocyte-specific high-mobility group box 1 deletion worsens the injury in liver ischemia/reperfusion: a role for intracellular high-mobility group box 1 in cellular protection | Q38959156 | ||
Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein | Q40609759 | ||
Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells | Q40686939 | ||
Rescue of cGMP kinase I knockout mice by smooth muscle specific expression of either isozyme | Q42519481 | ||
Increased adhesion and aggregation of platelets lacking cyclic guanosine 3',5'-monophosphate kinase I. | Q42944020 | ||
A mitogen-activated protein kinase-dependent signaling pathway in the activation of platelet integrin alpha IIbbeta3. | Q43720106 | ||
A stimulatory role for cGMP-dependent protein kinase in platelet activation | Q44277303 | ||
A platelet secretion pathway mediated by cGMP-dependent protein kinase | Q44997709 | ||
Activated platelets present high mobility group box 1 to neutrophils, inducing autophagy and promoting the extrusion of neutrophil extracellular traps. | Q45868008 | ||
Role of high-mobility group box 1 protein in post-infarction healing process and left ventricular remodelling | Q46264543 | ||
Benzyl alcohol attenuates acetaminophen-induced acute liver injury in a Toll-like receptor-4-dependent pattern in mice | Q47875295 | ||
Elevated high-mobility group box 1 levels in patients with cerebral and myocardial ischemia | Q48524719 | ||
Intracellular cyclophilin A is an important Ca(2+) regulator in platelets and critically involved in arterial thrombus formation. | Q51758034 | ||
HMGB1 binds to activated platelets via the receptor for advanced glycation end products and is present in platelet rich human coronary artery thrombi. | Q53412748 | ||
Macrophage migration inhibitory factor limits activation-induced apoptosis of platelets via CXCR7-dependent Akt signaling. | Q54318761 | ||
Systemic inflammation and remote organ injury following trauma require HMGB1 | Q60692866 | ||
Introduction: HMGB1 in inflammation and innate immunity | Q60746175 | ||
Circulating platelets as a source of the damage-associated molecular pattern HMGB1 in patients with systemic sclerosis | Q61780011 | ||
High-Mobility Group Box-1 in Ischemia-Reperfusion Injury of the Heart | Q63384080 | ||
Occurrence of amphoterin (HMG1) as an endogenous protein of human platelets that is exported to the cell surface upon platelet activation | Q73387665 | ||
Pf4-Cre transgenic mice allow the generation of lineage-restricted gene knockouts for studying megakaryocyte and platelet function in vivo | Q79220440 | ||
High-mobility group box 1 protein promotes development of microvascular thrombosis in rats | Q79613873 | ||
Hemorrhagic shock induces NAD(P)H oxidase activation in neutrophils: role of HMGB1-TLR4 signaling | Q80257425 | ||
IL-6 and maturation govern TLR2 and TLR4 induced TLR agonist tolerance and cross-tolerance in dendritic cells | Q81464256 | ||
Plasma concentrations and importance of High Mobility Group Box protein in the prognosis of organ failure in patients with disseminated intravascular coagulation | Q81641908 | ||
The correlation between platelet activation markers and HMGB1 in patients with disseminated intravascular coagulation and hematologic malignancy | Q83717385 | ||
Imaging the elastic modulus of human platelets during thrombin-induced activation using scanning ion conductance microscopy | Q85889876 | ||
Elevated mitochondrial membrane potential of circulating monocyte-platelet aggregates in patients with coronary heart disease | Q86253017 | ||
P4510 | describes a project that uses | ImageJ | Q1659584 |
P433 | issue | 12 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | thrombosis | Q261327 |
P304 | page(s) | 4638-4654 | |
P577 | publication date | 2015-11-09 | |
P1433 | published in | Journal of Clinical Investigation | Q3186904 |
P1476 | title | Platelet-derived HMGB1 is a critical mediator of thrombosis | |
P478 | volume | 125 |
Q57459347 | A shear-dependent NO-cGMP-cGKI cascade in platelets acts as an auto-regulatory brake of thrombosis |
Q93167734 | ABT-737 Triggers Caspase-Dependent Inhibition of Platelet Procoagulant Extracellular Vesicle Release during Apoptosis and Secondary Necrosis In Vitro |
Q40589554 | Aged Human Stored Red Blood Cell Supernatant Inhibits Macrophage Phagocytosis in an HMGB1 Dependent Manner After Trauma in a Murine Model |
Q64092947 | Alarmin HMGB1 and Soluble RAGE as New Tools to Evaluate the Risk Stratification in Patients With the Antiphospholipid Syndrome |
Q37353931 | Annexin A5 increases survival in murine sepsis model by inhibiting HMGB1-mediated pro-inflammation and coagulation. |
Q98224649 | COVID-19 and Diabetes: The Importance of Controlling RAGE |
Q61800023 | Cell Type-Specific Roles of NF-κB Linking Inflammation and Thrombosis |
Q51379114 | Comparative morphology analysis of live blood platelets using scanning ion conductance and robotic dark-field microscopy. |
Q91142640 | Cysteinyl leukotriene receptor 2 drives lung immunopathology through a platelet and high mobility box 1-dependent mechanism |
Q90707412 | Damage-associated molecular patterns in trauma |
Q48120840 | Deep vein thrombosis in mice is regulated by platelet HMGB1 through release of neutrophil-extracellular traps and DNA. |
Q26744644 | Disruption of a Regulatory Network Consisting of Neutrophils and Platelets Fosters Persisting Inflammation in Rheumatic Diseases |
Q42355573 | Disulfide HMGB1 derived from platelets coordinates venous thrombosis in mice |
Q91657132 | Effect of ultrapure lipopolysaccharides derived from diverse bacterial species on the modulation of platelet activation |
Q50249518 | Extracellular Cyclophilin A Augments Platelet-Dependent Thrombosis and Thromboinflammation |
Q90093923 | Extracellular DNA NET-Works With Dire Consequences for Health |
Q49630769 | From Human Megakaryocytes to Platelets: Effects of Aspirin on High-Mobility Group Box 1/Receptor for Advanced Glycation End Products Axis |
Q36034887 | HMGB1 Induces Secretion of Matrix Vesicles by Macrophages to Enhance Ectopic Mineralization |
Q96303601 | Hepatic Surgical Stress Promotes Systemic Immunothrombosis That Results in Distant Organ Injury |
Q28066302 | High Mobility Group Box-1: A Missing Link between Diabetes and Its Complications |
Q55251879 | High mobility group box 1 was associated with thrombosis in patients with atrial fibrillation. |
Q52591093 | High-Mobility Group Box 1 From Hypoxic Trophoblasts Promotes Endothelial Microparticle Production and Thrombophilia in Preeclampsia. |
Q47659060 | High-mobility group box 1 protein orchestrates responses to tissue damage via inflammation, innate and adaptive immunity, and tissue repair |
Q36812072 | Human plasma platelet-derived exosomes: effects of aspirin |
Q99594987 | Immunopathophysiology of trauma-related acute kidney injury |
Q50324081 | Immunothrombotic Activity of Damage-Associated Molecular Patterns and Extracellular Vesicles in Secondary Organ Failure Induced by Trauma and Sterile Insults |
Q47343207 | Inflammation and thrombosis: roles of neutrophils, platelets and endothelial cells and their interactions in thrombus formation during sepsis |
Q88194461 | Inhibitory mechanisms of very low-dose rivaroxaban in non-ST-elevation myocardial infarction |
Q51740307 | Intravenous administration of synthetic platelets (SynthoPlateTM) in a mouse liver injury model of uncontrolled hemorrhage improves hemostasis. |
Q51332285 | Is Coagulopathy an Appropriate Therapeutic Target During Critical Illness Such as Trauma or Sepsis? |
Q45903686 | Neuroprotective Effect of β-Caryophyllene on Cerebral Ischemia-Reperfusion Injury via Regulation of Necroptotic Neuronal Death and Inflammation: In Vivo and in Vitro. |
Q39147112 | New Concepts and Mechanisms of Platelet Activation Signaling |
Q48881688 | Nucleic acid scavenging microfiber mesh inhibits trauma-induced inflammation and thrombosis |
Q93061149 | Organ Preservation into the 2020s: The Era of Dynamic Intervention |
Q88123532 | Platelet HMGB1 is required for efficient bacterial clearance in intra-abdominal bacterial sepsis in mice |
Q42155026 | Platelet-derived high-mobility group box 1 promotes recruitment and suppresses apoptosis of monocytes |
Q48136773 | Platelets at the crossroads of thrombosis, inflammation and haemolysis. |
Q92405179 | Platelets in Sepsis: An Update on Experimental Models and Clinical Data |
Q92063054 | Platelets: emerging facilitators of cellular crosstalk in rheumatoid arthritis |
Q90644496 | Quantifying single-platelet biomechanics: An outsider's guide to biophysical methods and recent advances |
Q49494782 | Recombinant Film and Opportunity |
Q93062713 | Regulation of Innate Immune Responses by Platelets |
Q38682450 | Regulation of Posttranslational Modifications of HMGB1 During Immune Responses |
Q90314951 | TLR4-dependent upregulation of the platelet NLRP3 inflammasome promotes platelet aggregation in a murine model of hindlimb ischemia |
Q52668322 | The Neutrophil's Choice: Phagocytose vs Make Neutrophil Extracellular Traps. |
Q52725381 | The non-haemostatic role of platelets in systemic lupus erythematosus. |
Q90290881 | The platelet NLRP3 inflammasome is upregulated in a murine model of pancreatic cancer and promotes platelet aggregation and tumor growth |
Q57795879 | The platelet NLRP3 inflammasome is upregulated in sickle cell disease via HMGB1/TLR4 and Bruton tyrosine kinase |
Q88671029 | The role of platelets in acute kidney injury |
Q89521703 | The role of type 1 interferons in coagulation induced by gram-negative bacteria |
Q38690221 | Thrombin-induced cytoskeleton dynamics in spread human platelets observed with fast scanning ion conductance microscopy |
Q47147432 | Toll-Like Receptor 4 Signalling and Its Impact on Platelet Function, Thrombosis, and Haemostasis. |
Q50115928 | Translational Implications of Platelets as Vascular First Responders |
Q50608446 | Uncontrolled Hemorrhagic Shock Modeled via Liver Laceration in Mice with Real Time Hemodynamic Monitoring. |
Q26745898 | Until Death Do Us Part: Necrosis and Oxidation Promote the Tumor Microenvironment |
Q92191429 | Use of a high platelet-to-RBC ratio of 2:1 is more effective in correcting trauma-induced coagulopathy than a ratio of 1:1 in a rat multiple trauma transfusion model |
Q26749091 | Vascular Remodelling and Mesenchymal Transition in Systemic Sclerosis |
Search more.